retatrutide triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide (LY3437943): Mechanism of Action

Helps manage common GLP-1 side effects

Can Retatrutide improve your mental health

Based on a systematic synthesis of available findings, we conclude that there is considerable support for the neuromodulatory potential of gut-based circulating peptides on reward responses

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2

Compare 10 GLP-1 agonist medications for weight loss including semaglutide and tirzepatide

10mg/vial (single vial)